The Multifaceted Roles of Biomarkers in Metabolic Disorders: From Diagnosis and Monitoring to Prediction, Management, and Treatment

Dear Colleagues,

The increasing prevalence of metabolic disorders such as obesity, type 2 diabetes, and cardiovascular disease highlights the pressing need for innovative approaches to diagnosis, treatment, and prevention. The identification of functional biomarkers, including metabolites, microRNAs, and proteins, is crucial, as they can serve as early indicators of pathological dysfunction and damage, even before the onset of disease. Additionally, investigating the metabolic disturbances caused by drugs, nutrients, and environmental factors can elucidate the underlying biochemical pathways involved in these disorders and their complications. By developing novel analytical methods for biomarker analysis, we can gain valuable insights into tissue-specific metabolic disruptions, which could completely transform our understanding of the pathophysiology of metabolic disorders. Furthermore, studying biomarkers that predict treatment responses and integrating multi-biomarker data offer avenues for the implementation of personalized medicine strategies, ultimately leading to enhanced clinical outcomes. This comprehensive approach holds the potential to transform diagnostics, patient risk assessment, and therapeutic interventions for metabolic disorders. We welcome original research articles as well as in-depth reviews covering these topics.

Dr. Prince Dadson
Dr. Miikka-Juhani Honka
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Metabolites is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.